Müller F O, Hundt H K, Bromley P A, Torres J, Vanderbeke O
Clin Pharmacol Ther. 1979 May;25(5 Pt 1):528-35. doi: 10.1002/cpt1979255part1528.
Penbutolol, a nonselective beta-adrenoreceptor antagonist, induced reduction of exercise-induced heartbeats for at least 24 hr after a single 40-mg oral dose, and was equipotent with respect to a 2 X 20-mg regimen over the same period. Ingestion for 7 days did not influence the pharmacodynamics or pharmacokinetics of penbutolol, and there was no cumulation of drug in serum. A relationship was found between the logarithms of measurable serum concentrations of penbutolol and the percentage reduction of total heartbeats. Absorption of oral penbutolol appeared to be reduced when administered in the evening. Since beta-adrenoceptor activity was relatively unchanged between 13 and 24 hr after a single 40-mg dose of penbutolol, there is a possibility that an active metabolite or metabolites may contribute to prolonged duration of action.
喷布洛尔是一种非选择性β-肾上腺素能受体拮抗剂,单次口服40毫克剂量后,可使运动诱发的心跳次数减少至少24小时,且在同一时期内,其效果与2×20毫克的给药方案相当。连续服用7天对喷布洛尔的药效学或药代动力学没有影响,血清中也没有药物蓄积。喷布洛尔可测血清浓度的对数与总心跳次数减少的百分比之间存在相关性。晚上服用时,口服喷布洛尔的吸收似乎会减少。由于单次服用40毫克喷布洛尔后13至24小时内β-肾上腺素能受体活性相对不变,因此有可能一种或多种活性代谢物会导致作用时间延长。